Cargando…
Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
BACKGROUND: Underlying inflammation has been increasingly recognized in heart failure with a preserved ejection fraction (HFpEF). In this study we tested the hypothesis that pro‐inflammatory biomarkers are elevated in patients with acutely decompensated HFpEF (AD‐HFpEF) compared with patients with s...
Autores principales: | Abernethy, Abraham, Raza, Sadi, Sun, Jie‐Lena, Anstrom, Kevin J., Tracy, Russell, Steiner, Johannes, VanBuren, Peter, LeWinter, Martin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015440/ https://www.ncbi.nlm.nih.gov/pubmed/29650706 http://dx.doi.org/10.1161/JAHA.117.007385 |
Ejemplares similares
-
Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Luo, Nancy, et al.
Publicado: (2021) -
Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry
por: Seo, Masahiro, et al.
Publicado: (2022) -
Prognostic Importance of Pulmonary Arterial Capacitance in Acute Decompensated Heart Failure With Preserved Ejection Fraction
por: Nakagawa, Akito, et al.
Publicado: (2021) -
Heart Rate–Induced Myocardial Ca(2+) Retention and Left Ventricular Volume Loss in Patients With Heart Failure With Preserved Ejection Fraction
por: Silverman, Daniel N., et al.
Publicado: (2020) -
Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis
por: Basile, Christian, et al.
Publicado: (2023)